CMS Moratorium 2026: A Nationwide Freeze on New DMEPOS Enrollments
On February 27, 2026, CMS enacted a 180-day nationwide moratorium on new Medicare enrollments for seven categories of DMEPOS suppliers under the CMS-6099-N notice.
This action has immediate and widespread implications:
No new PTANs will be issued during the moratorium period
Applications submitted after the effective date are denied, not delayed
The freeze is expected to last through late August 2026
This is not a procedural slowdown—it is a complete stop on new Medicare billing access for affected suppliers.
For any business planning to enter the DMEPOS market in 2026, this effectively blocks the ability to begin operations tied to Medicare reimbursement.
Why the PTAN Is Critical to Your Revenue Pipeline
For DMEPOS suppliers and pharmacies, the PTAN is foundational. It is not just a Medicare billing number—it is the gateway to participation across nearly all payer systems.
Without an active Medicare enrollment:
Medicaid provider agreements are often unobtainable
Commercial insurance payers may deny or ignore contract applications
Referral networks may be limited or unavailable
For new businesses, this creates a cascading effect:
Inventory is purchased
Leases are signed
Staff is hired
But without a PTAN, there is no path to reimbursement.
The result is not simply delayed Medicare revenue—it is often a full revenue blackout across all payer sources.
The 36-Month Rule: Why Ownership Changes Are Also Blocked
The impact of the moratorium extends beyond new businesses. It also affects organizations undergoing ownership changes.
Under CMS’s 36-Month Rule:
If a Medicare-enrolled business transfers more than 50% ownership
Within the first 36 months of enrollment
CMS may treat the transaction as a new enrollment.
Under normal circumstances, this would trigger a re-enrollment process. However, during the moratorium:
New enrollments are not being approved
Ownership transitions may result in application denial
This creates significant risk for:
Business acquisitions
Ownership restructuring
Partnership changes
In practical terms, a completed sale could leave the new owner with:
A physical location
Operational staff
Active patients
But no legal ability to bill Medicare or other payers tied to enrollment status.
Increased Enforcement: Protecting Existing PTANs
While new enrollments are paused, CMS is shifting its focus toward active providers who already hold a PTAN.
Enforcement is becoming more proactive and immediate, with increased use of:
Unannounced site inspections
Real-time data validation across systems
Documentation audits tied to enrollment records
Common compliance risks include:
Inaccurate or outdated NPPES (NPI) data
Mismatched information between PECOS and operational records
Missing or non-compliant facility requirements (e.g., fitting areas)
Incomplete or inconsistent documentation
Even minor administrative issues can now trigger:
Enrollment revocation
Suspension of billing privileges
Delays in claims processing
CMS is moving toward a model where compliance is continuously monitored, not periodically reviewed.
What DMEPOS Suppliers Should Do Right Now
In the current regulatory environment, protecting your existing enrollment is critical.
Key steps include:
Ensure PECOS and NPPES data are fully aligned and up to date
Maintain accurate ownership and managing employee records
Verify that your facility meets all DMEPOS accreditation requirements at all times
Prepare for unannounced inspections by keeping documentation accessible and current
Monitor all enrollment-related deadlines and updates
The focus is no longer just on getting enrolled—it is on staying compliant at all times.
A Shift Toward Defensive Compliance
The 2026 moratorium reflects a broader shift in CMS oversight. The system is moving toward:
Stricter enrollment control
Real-time compliance enforcement
Immediate consequences for discrepancies
For DMEPOS suppliers, this creates a more fragile operating environment.
Your PTAN is no longer just a credential—it is a continuously evaluated asset that requires active management.
Maintaining compliance is now essential to ensuring:
Ongoing reimbursement
Stable payer relationships
Continued patient service delivery
How PACCS Supports DMEPOS Enrollment & Compliance
Navigating Medicare enrollment restrictions, ownership rules, and ongoing compliance requirements can be complex—especially in a rapidly changing regulatory environment.
PACCS (Pharmacy Administrative Credentialing & Compliance Services) helps DMEPOS suppliers and pharmacies manage these challenges with:
Medicare and Medicaid enrollment support
DMEPOS credentialing and accreditation coordination
Ownership change and re-enrollment strategy
PECOS and NPPES data management
Compliance monitoring and documentation oversight
Payer communication and issue resolution
By ensuring your enrollment data is accurate and your compliance processes are aligned, PACCS helps protect your billing privileges, revenue continuity, and operational stability.
To learn more, visit our Services page or contact PACCS to discuss how we can support your organization.
Sources
https://nppes.cms.hhs.gov/
https://pecos.cms.hhs.gov/
Investigative Dispatch — PACCS Editorial Series
Insights on regulatory developments affecting pharmacy credentialing, Medicare enrollment, and compliance.
Sterling Bly | Investigative Healthcare Blogger
